-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK INITIATES PHASE 3 STUDY EVALUATING OHTUVAYRE® (ENSIFENTRINE) FOR THE PREVENTION OF COPD EXACERBATIONS IN ADULT PATIENTS RECEIVING STANDARD OF CARE WITH A HISTORY OF EXACERBATIONS

Reuters·11/03/2026 11:46:27